Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsAmeriHealth PrEP Coverage Policy Update | OpenPaye…
    Ask Trek AI about this page
    CurrentAmeriHealthPolicy N/A

    Preventive HIV Pre-Exposure Prophylaxis (PrEP) Medications Coverage

    Customize your policy alerts

    Sign up for all AmeriHealth policy alerts

    Know when AmeriHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines AmeriHealth coverage for HIV pre-exposure prophylaxis (PrEP) medications provided as preventive care at no cost-sharing under the ACA/USPSTF recommendation; affects members using PrEP for HIV prevention.

    Policy Summary
    PayerAmeriHealth
    PolicyPreventive HIV Pre-Exposure Prophylaxis (PrEP) Medications Coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateN/A
    Key ActionDocument that the medication is being used for HIV prevention (PrEP) to qualify for $0 preventive coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    100%cost-share for covered preventive PrEP medications
    0patient cost when used for prevention
    4listed PrEP products at $0

    Coverage Criteria

    Preventive coverage criteria

    Covered at $0 when used for HIV prevention for members at increased risk.

    Coverage conditions: Member is using the medication for HIV pre-exposure prophylaxis (PrEP) and the medication is one of the listed preventive products

    Medications used for treatment of HIV infection are covered under the normal pharmacy benefit with usual cost-sharing.

    Medications used for treatment of HIV infection are excluded from the $0 preventive benefit under this policy. When a listed product is prescribed for treatment of HIV infection rather than for prevention (pre-exposure prophylaxis), it will be processed under the member's normal pharmacy benefit and is subject to usual cost-sharing, including copayments, coinsurance, and deductible as applicable.

    Provider Actions and Requirements

    Prior Authorization
    Policy Summary
    PayerAmeriHealth
    PolicyPreventive HIV Pre-Exposure Prophylaxis (PrEP) Medications Coverage
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJul 1, 2026
    Last ReviewJul 1, 2026
    Next Review DateN/A
    Key ActionDocument that the medication is being used for HIV prevention (PrEP) to qualify for $0 preventive coverage.
    SourceLink
    On This Page
    Coverage CriteriaProvider Actions and RequirementsListed Preventive ProductsDefinitionsBackground

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    No prior authorization required for listed PrEP medications

    No prior authorization is required for the PrEP medications listed as available at $0 when used for HIV prevention under this policy.

    Step Therapy

    No step therapy requirements

    The policy does not impose step therapy requirements for the listed PrEP medications.

    Documentation Required

    Document PrEP indication for $0 preventive coverage

    Document in the claim or medical record that the medication is being prescribed and used for HIV prevention (pre‑exposure prophylaxis) so the $0 preventive benefit applies.

    • Indication must reflect use for HIV prevention (PrEP) rather than treatment of HIV infection.
    Denial Risk

    $0 coverage only for PrEP (prevention) — treatment uses follow normal benefit

    Coverage at $0 applies only when these medications are used for HIV prevention (PrEP); when used to treat HIV infection they are processed under the normal pharmacy benefit with usual member cost‑sharing.

    • Ensure claims and documentation clearly indicate prevention vs treatment to avoid incorrect cost‑sharing.
    • Medications listed as preventive are available at $0 for members using them for prevention.

    Listed Preventive Products

    Products listed as preventive

    Listed products available at $0 for members using them for prevention.

    Listed products: Emtricitabine-tenofovir disoproxil fumarate 200-300 mg tablet (generic Truvada) — Truvada available if unable to take generic; Tenofovir disoproxil fumarate 300 mg tablet (generic Viread) — Viread available if unable to take generic; Apretude ER 600 mg/3 mL injection; Descovy 200-25 mg tablet

    Specific product selection may depend on clinical appropriateness and ability to take generics vs brand.

    Definitions

    HIV PrEP — Definition & key points
    DefinitionPre-Exposure Prophylaxis (PrEP): antiretroviral medication taken by HIV-negative individuals to reduce the risk of HIV acquisition.
    Coverage contextPrEP medications are offered at $0 when used for HIV prevention under the Affordable Care Act and USPSTF recommendation.
    Target populationIndividuals at increased risk of becoming infected with HIV but who are not yet infected.
    Benefit distinctionMedications used for treatment of HIV infection are covered under the standard pharmacy benefit (with normal copays/coinsurance/deductible) rather than the $0 preventive benefit.
    Effective dateUpdated July 1, 2026.

    Background

    This coverage reflects the Patient Protection and Affordable Care Act requirement and the United States Preventive Services Task Force (USPSTF) recommendation that certain preventive medications for individuals at increased risk of HIV infection be provided without cost-sharing. Under this policy, HIV Pre-Exposure Prophylaxis (PrEP) medications are offered at $0 when used for prevention for members who are not infected but have an increased risk of acquiring HIV.

    Providers should note that the $0 preventive coverage applies only when the medication is being used for PrEP; if the medication is used for treatment of HIV infection it will be covered under the standard pharmacy benefit with the member’s usual cost-sharing.